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L
ichen planus (LP) is a common T-cell-mediated 
chronic inflammatory disease of the stratified 
squamous epithelium, with unknown etiology. It can 
affect oral mucosa, the skin, genitalia, hair follicles, 
nails, esophagus, urinary tract, nasal mucosa, larynx 
and even the eyes (1). Local conditions such as poor 
oral hygiene and smoking may increase the chance of 
the immune trigger by increasing the exposure.
Oral LP (OLP) affects women more than men (1,2) 
and  occurs  predominantly  in  adulthood,  although 
young  people  and  children  might  be  affected  (1). 
Clinically, the OLP has six variants: Papular, reticular, 
plaque-like,  atrophic,  erosive  and  bullous.  These 
features may occur individually or in combination 
(2). There is ongoing concern that OLP may be pre-
malignant (3). 
While skin lesions occur in 20% of patients with 
OLP, cutaneous lesions are associated with oral lesions 
in 70%–77% of cases (4). The oral mucosa in OLP is 
highly accessible for an accurate examination. Therefore, 
OLP is ideal for the study of human T-cell-mediated 
inflammation  and  autoimmunity  (5-7).  Oral  lesions 
are characteristically raised multiform white lesions, 
accompanied by areas of erosions and pigmentation 
(1). Histological features of the LP are nonspecific and 
there are no well-accepted criteria for its diagnosis (8) 
which makes its definite diagnosis difficult.
Hepatitis  C  virus  (HCV)  is  a  single-stranded 
RNA virus which is recognized as a global concern 
(9). Worldwide, more than 170 million people are 
infected with HCV (10). The virus has an extremely 
variable genome, six distinct genotypes and multiple 
subtypes (5). It is estimated that 0.16% of the Iranian 
general population are infected with the virus (11). 
Infection with HCV has been found to be a major 
cause of liver diseases. Although the incidence of HCV 
infection is significantly lower than that of hepatitis 
B  virus  (HBV)  infection,  the  rate  of  chronically 
infected individuals is much higher (12). Morbidity 
associated with HCV infection is not only due to the 
sequelae of chronic liver disease, but is also due to a 
variety of extrahepatic manifestations (5). There is no 
efficient vaccine available and it seems too optimistic 
to predict one in the near future. More epidemiologic 
studies are needed to better assess the epidemiological 
characteristic of the disease (13). Correlation between 
HCV  infection  and  some  oral  diseases  such  as 
OLP, Sjögren’s syndrome, and sialadenitis has been 
reported. Moreover, OLP was found associated with 
a number of viral infections including Epstein-Barr 
virus, cytomegalovirus, varicella zoster virus, human 
herpes virus , human papilloma virus, and human 
immunodeficiency virus (HIV). However, the most 
frequent evidence relates to HCV infection (14, 15). Hepatitis Monthly, Summer 2010; 10(3): 161-164
162 HCV and Lichen Planus
If this would be a true association, OLP in certain 
populations may be used as a sign of HCV infection 
in asymptomatic patients, leading to early diagnosis 
and treatment, and possibly a better prognosis of the 
infected patients (5, 14, 16). 
The  first  description  of  this  association  was 
reported in 1991, just two years after discovery of 
HCV (17). During the past years, studies from Taiwan 
(18), Brazil (19), Israel (20), Saudi Arabia (21), Turkey 
(22), Iran (23) and Thailand (24) showed statistically 
significant correlation between presence of LP and 
HCV infection. A study from Japan reported that 
the prevalence of OLP increased as the subjects grew 
older (25). On the other hand, many researchers found 
no correlation between chronic HCV infection and 
LP.  An  Italian  study  showed  just  a  weak  relation 
between HCV infection and OLP (26). Another two 
Italian studies (27, 28), two Indian studies (29, 30) two 
Iranian studies (31, 32), one Brazilian study (33), one 
Turkish study (34), one Serbian study (35) and one 
from UK (36) were not able to find any correlation 
between chronic HCV infection and LP.
A recent meta-analysis exploring the association 
between  HCV  and  LP,  nonetheless,  revealed  an 
important association. The pooled odds ratio point 
estimate of the prevalence of HCV infection among 
patients with LP was 5.4 (95% confidence interval 
[CI]:  3.5–8.3),  compared  to  the  control  subjects. 
The odds ratio for LP among patients with HCV 
compared to control participants was 2.5 (95% CI: 
2.0–3.1) (37). 
The  most  likely  hypothesis  describing  the 
association of HCV infection and LP is regional-
based correlation (37, 38). Nevertheless, it seems very 
superficial  to  just  conclude  a  simple  geographical 
correlation. This non-homogeneity in results from 
different geographic areas may have several reasons. 
Many of these reports for LP come from registries 
of  hospitals  or  university  affiliated  clinics.  These 
cannot  represent  the  real  situation  in  the  general 
population for sure. Difficulties in making a definite 
diagnosis for LP—as previously mentioned—make 
interpretation even more complex. Estimation of the 
point prevalence of HCV infection in the general 
population in these regions and how well the control 
group was selected are other contributing variables 
which may lead to divergent results. Also, as HCV 
treatment, especially interferon-α, may provoke oral 
lesions similar to OLP (39), lack of information on 
the treatment status of enrollees with HCV infection 
in  many  of  these  studies  makes  summarizing  the 
results challenging (37).
Analysis of available data revealed that it is too 
premature  to  reach  a  definite  conclusion.  So  far, 
the most plausible path for this association is based 
on various factors such as region. Furthermore, we 
need  to  find  the  underlying  mechanisms  for  the 
association. Experimental data strongly suggest that 
HCV is involved in the pathogenesis of OLP through 
local induction of an immune response specific for 
HCV epitopes (5). 
HCV RNA has been detected both in sera and in 
oral lesions of patients with OLP; however no direct 
pathogenic  effect  of  HCV  on  oral  mucosa  could 
be  demonstrated  (40-42).  Theoretically,  epitopic 
similarities between HCV and keratinocytes could 
explain the association between LP and HCV, but 
this could not be demonstrated in any studies. It 
is believed that this association might be related to 
cytotoxic immune response to epithelia cells infected 
with HCV (41, 43).
In some of these reports, HCV infected patients 
with LP had a higher serum transaminase level, and 
a higher chance of being diabetic than those without 
LP (37, 44). On the other hand, oral lesions in patients 
with HCV infection with LP were more likely to be 
erosive, when compared to non-infected LP patients 
(45-47). This may reflect a synergistic effect between 
the two conditions. Interestingly, co-infection with 
HIV decreases the possibility of LP in HCV-infected 
patients,  probably  through  an  immunodeficiency 
state  (48,  49).  It  should  be  mentioned  that  no 
correlation was observed between the viral load and 
HCV genotype and the likelihood of developing LP 
in HCV-infected patients (50-52).
Overall, it can be concluded that HCV-infected 
patients may have increased risk of developing LP 
or alternatively, patients with LP may be at a higher 
risk for developing HCV infection (38). Altogether, 
screening OLP patients for antibodies to HCV is 
recommended (20). More prospective well-designed 
studies (especially cohorts) are necessary to clarify 
the above issue.
There are some reports of association between LP 
and other chronic liver diseases including primary 
biliary cirrhosis, and cirrhosis of unknown origin. 
This may indicate other modes of interaction.
Why  is  this  association  important?  As  HCV 
infection  is  usually  indolent  so  that  patients  may 
present only in late stages of the disease with serious 
complications like cirrhosis and chronic liver disease, 
screening  of  patients  with  LP  may  help  in  early 
diagnosis of the HCV infection in a subset of patients. 
Early diagnosis, education and awareness of these 
patients may decrease risk of transmission to others. 
In a cost-effectiveness analysis, screening of patients 
with LP with ELISA was found cost-effective only 
with the presence of other risk factors such as history 
of intravenous drug abuse (IVDU), sex with IVDU , 
or history of transfusion (53, 54).Hepatitis Monthly, Summer 2010; 10(3): 161-164
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Reviewing these findings may help us in better 
understanding the pathogenesis of HCV infection, 
especially its extrahepatic manifestations. It should 
be emphasized that the epidemiologic studies could 
not prove any causative role for HCV in LP.
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